课题基金 / 基金详情

Investigating the molecular mechanisms mediating the anti-cancer properties of resveratrol

Investigating the molecular mechanisms mediating the anti-cancer properties of resveratrol
研究介导白藜芦醇抗癌特性的分子机制
批准号:
2737154
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Substances that we are exposed to through the diet can have positive or negative effects on our health. Phytochemicals such as resveratrol have been reported to have overall beneficial effects, including anti-inflammatory, anti-ageing and anti-cancer properties. Intriguingly, activation of repetitive DNA elements such as LINE1s that are usually silenced in healthy cells, has been associated with ageing and cancer through modulation of inflammatory pathways. Work from the host group and others has shown that resveratrol treatment can alter the activity of repetitive elements. Moreover, preliminary work from the host group using resveratrol pull downs has found that a transcription factor known to regulate the activity of repetitive elements directly interact with resveratrol. These observations led to the hypothesis that the health beneficial effects of resveratrol are in part mediated by its ability to modulate LINE1 expression through this interaction. This project aims to study the molecular mechanisms through which the interaction of resveratrol with this transcription factor regulates LINE1 expression. The proposed work will characterise the interaction and investigate its functional consequences using a combination of biochemical, structural and cell biology approaches combined with multi-omics analyses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
  • 批准号:
    82371616
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨成
  • 依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
  • 批准号:
    82370981
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    陈敏洁
  • 依托单位:
PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
  • 批准号:
    82372073
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张淼
  • 依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
  • 批准号:
    82371652
  • 项目类别:
    面上项目
  • 资助金额:
    45.00万元
  • 批准年份:
    2023
  • 负责人:
    刘开江
  • 依托单位: